Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-TBEV Envelope protein E Antibody (13D6)

Catalog #:   RVV28901 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA, RIA, SPR, WB
Accession: Q01299
Overview

Catalog No.

RVV28901

Species reactivity

Tick-borne encephalitis virus (strain Hypr) (TBEV)

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

Genome polyprotein, Envelope protein E

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q01299

Applications

ELISA, RIA, SPR, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

13D6

Data Image
References

Antibodies against 12 infectious agents in free-ranging Eurasian beaver (Castor fiber L.) from the Czech Republic., PMID:40090533

Tick-borne encephalitis virus seroprevalence and infection incidence in Switzerland, 2020-2021., PMID:40069290

Phage Display Revealed the Complex Structure of the Epitope of the Monoclonal Antibody 10H10., PMID:39408641

Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity., PMID:39133062

Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins., PMID:39112523

Predicting immune response targets in orthoflaviviruses through sequence homology and computational analysis., PMID:39083139

Comparison of Five Serological Methods for the Detection of West Nile Virus Antibodies., PMID:38793670

[Preparation of monoclonal antibodies against the envelope protein extracellular domain of Zika virus in mice]., PMID:38790101

Multiplex Serology for Sensitive and Specific Flavivirus IgG Detection: Addition of Envelope Protein Domain III to NS1 Increases Sensitivity for Tick-Borne Encephalitis Virus IgG Detection., PMID:38400061

Results of Tick-Borne Encephalitis Virus (TBEV) Diagnostics in an Endemic Area in Southern Germany, 2007 to 2022., PMID:38140598

Antiviral activity of porphyrins and porphyrin-like compounds against tick-borne encephalitis virus: Blockage of the viral entry/fusion machinery by photosensitization-mediated destruction of the viral envelope., PMID:38040199

Recombinant TBEV Protein E of the Siberian Subtype Is a Candidate Antigen in the ELISA Test System for Differential Diagnosis., PMID:37892100

Vaccination against tick-borne encephalitis elicits a detectable NS1 IgG antibody response., PMID:37838083

New Neutralizing Epitope Exposed on the Domain II of Tick-Borne Encephalitis Virus Envelope Glycoprotein E., PMID:37376556

Development of a novel virus-like particle-based vaccine for preventing tick-borne encephalitis virus infection., PMID:37328107

Horses as Sentinels for the Circulation of Flaviviruses in Eastern-Central Germany., PMID:37243194

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection., PMID:37153588

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial., PMID:36758067

Functional characterization and immunogenicity of a novel vaccine candidate against tick-borne encephalitis virus based on Leishmania-derived virus-like particles., PMID:36581050

Progressive Course of Chronic Tick-Borne Encephalitis Manifesting as Amyotrophic Lateral Sclerosis-like Syndrome 35 Years after the Acute Disease., PMID:36009082

Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses?, PMID:35887069

Sensitisation and allergic reactions to alpha-1,3-galactose in Podlasie, Poland, an area endemic for tick-borne infections., PMID:35382677

Tick-borne encephalitis nonstructural protein NS1 expressed in E. coli retains immunological properties of the native protein., PMID:34920135

Computational and Rational Design of Single-Chain Antibody against Tick-Borne Encephalitis Virus for Modifying Its Specificity., PMID:34452359

Phylogenetic analysis of tick-borne encephalitis virus strains found in an engorged tick and traveler returning from Russia., PMID:33571754

A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins., PMID:33022219

The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection., PMID:32988388

Comprehensive N-glycosylation mapping of envelope glycoprotein from tick-borne encephalitis virus grown in human and tick cells., PMID:32764711

Characterization of neutralizing monoclonal antibody against tick-borne encephalitis virus in vivo., PMID:32409136

Revealing new tick-borne encephalitis virus foci by screening antibodies in sheep milk., PMID:32268924

Multi-laboratory evaluation of ReaScan TBE IgM rapid test, 2016 to 2017., PMID:32234120

Tick-borne encephalitis foci in northeast Italy revealed by combined virus detection in ticks, serosurvey on goats and human cases., PMID:32100632

Innate and adaptive immunity in wild rodents spontaneously and experimentally infected with the tick-borne encephalitis virus., PMID:31927073

A method for rapid and high-yield production of the tick-borne encephalitis virus E and DIII recombinant proteins in E. coli with preservation of the antigenic properties., PMID:31072731

Preparation and Investigation of Silver Nanoparticle⁻Antibody Bioconjugates for Electrochemical Immunoassay of Tick-Borne Encephalitis., PMID:31067666

First detection of TBE virus in ticks and sero-reactivity in goats in a non-endemic region in the southern part of Switzerland (Canton of Ticino)., PMID:31047827

Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus., PMID:31015334

Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus., PMID:30958863

The Dengue ED3 Dot Assay, a Novel Serological Test for the Detection of Denguevirus Type-Specific Antibodies and Its Application in a Retrospective Seroprevalence Study., PMID:30934772

Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus., PMID:30760569

Immunogenicity and Protective Activity of a Chimeric Protein Based on the Domain III of the Tick-Borne Encephalitis Virus E Protein and the OmpF Porin of Yersinia pseudotuberculosis Incorporated into the TI-Complex., PMID:30274357

Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients., PMID:30204244

Recombinant Fusion Protein Joining E Protein Domain III of Tick-Borne Encephalitis Virus and HSP70 of Yersinia pseudotuberculosis as an Antigen for the TI-Complexes., PMID:30149603

Experimental Evaluation of the Protective Efficacy of Tick-Borne Encephalitis (TBE) Vaccines Based on European and Far-Eastern TBEV Strains in Mice and in Vitro., PMID:30061869

Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation Assay for Flavivirus Antiviral Screening., PMID:29997331

A cluster of two human cases of tick-borne encephalitis (TBE) transmitted by unpasteurised goat milk and cheese in Germany, May 2016., PMID:29667575

Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection InVitro and in a Mouse Model., PMID:29435494

Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody., PMID:29382836

Engineering of Chimeric Protein Based on E Protein Domain III of Tick- Borne Encephalitis Virus and OmpF Porin of Yersinia pseudotuberculosis., PMID:28741465

A label-free immunoassay for Flavivirus detection by the Reflective Phantom Interface technology., PMID:28501619

Datasheet
$ 372
Product specifications
100 μg 372 1 mg 1860

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-TBEV Envelope protein E Antibody (13D6) [RVV28901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only